The COVID Project
The record
- Jurisdiction
- New Jersey - Department of Health (State health department) · New Jersey
- Level
- State
- Authority
- N.J.S.A. 26:13-1 et seq.; Executive Directive 20-012
- Issued
- 2020-05-12 May 12, 2020
- Effective
- immediately (read as 2020-05-12)
- End
- 'shall remain in force and [effect]' for the emergency; revised Dec. 20, 2021 (post-period) (read as 2021-12-20)
- In force
- May 12, 2020 to Dec. 20, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Health care ordersWorkplace rulesOther
- Addressees
- health care providers, licensed pharmacists, testing locations and laboratories
- Functions reached
- DX diagnostics (pharmacy and site-based testing)
- HR screening (employer testing programs)
- OF reporting
- Collection
- State health department orders to licensed settings AGY-ST-HEALTH-SUBORDERS
Operative words
This standing order is issued pursuant to the New Jersey Emergency Health Powers Act, N.J.S.A. [26:13-1 et seq.]... This standing order authorizes any healthcare provider, licensed pharmacist (to the extent [permitted])... II. PATIENT ELIGIBILITY... [testing locations acting under this] standing order shall report the test results to the healthcare facility, pharmacy (as authorized [by the individual])... A. Test results must be reported to the individual by a representative of the testing location... B. Positive and negative results must be reported by the laboratory processing the test results [to the Department]... This standing order shall take effect immediately.
Enforcement
N.J.S.A. 26:13-19; N.J.A.C. 8:57 (reporting)